跳至主要内容
临床试验/NCT02246504
NCT02246504已完成不适用

Registry - Use of a High Intensity Focused Ultrasound (HIFU) in Patients With Non-malignant Thyroid Nodules.

Theraclion2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年10月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Theraclion
入组人数
20
试验地点
2
主要终点
Change from baseline in thyroid nodule's volume

研究概览

简要总结

The purpose of this study is to evaluate thyroid nodule's volume, structure and vascularisation changes following HIFU therapy assessed by ultrasonography

详细描述

HIFU treatment will be performed under conscious sedation under the supervision / responsibilities of an anesthetist.

A maximum of 2 HIFU sessions per nodule will be performed per patient. The decision to retreat the patient will be taken at 1 month post-HIFU or later.

Follow-up after HIFU treatment

D1 after HIFU session:

  • Indirect laryngoscopy to check vocal cord mobility.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patient 18 years or older.
  • Patient presenting with at least one thyroid nodule with no signs of malignancy:
  • Non suspect clinically and at ultrasonography imaging
  • Benign cytological diagnosis at FNAB from the last 6 months
  • Normal serum calcitonin
  • No history of neck irradiation
  • Normal TSH.
  • Targeted nodule accessible and eligible to HIFU
  • Absence of abnormal vocal cord mobility at laryngoscopy.
  • Nodule diameter ≥ 10mm measured by ultrasound.
  • Composition of the targeted nodule(s) : no more than 30% cystic

排除标准

  • Head and/or neck disease that prevents hyperextension of neck.
  • Known history of thyroid cancer or other neoplasias in the neck region.
  • History of neck irradiation.
  • Macrocalcification inducing a shadow in the thyroid significant enough to preclude the HIFU treatment
  • Posterior position of the nodule if the thickness of the nodule is <15mm
  • Pregnant or lactating woman
  • Any contraindication to IV neurolept analgesia.

研究组 & 干预措施

HIFU treatment

Experimental

use of HIFU treatment in patients with non-malignant thyroid nodules

干预措施: HIFU treatment (Device)

结局指标

主要结局

Change from baseline in thyroid nodule's volume

时间窗: Month 6

次要结局

  • Number of participants with adverse events(D1, D7, M1, M3 and M6)
  • Change from baseline in thyroid nodule's structure and vascularisation(Month 6)

研究者

发起方
Theraclion
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验